In patients with melanoma, there are data showing that CD8+ T cells are similarly depleted in extra-hepatic and hepatic metastases, suggestive of a more systemic effect at play.8 We also identified a subgroup of patients who had an extra-hepatic response and progressive disease in the liver. This evidence concerns the gene CD8A and melanoma.